- Previous Close
0.0390 - Open
0.0390 - Bid --
- Ask --
- Day's Range
0.0390 - 0.0390 - 52 Week Range
0.0390 - 0.0390 - Volume
131 - Avg. Volume
-- - Market Cap (intraday)
-- - Beta (5Y Monthly) 0.40
- PE Ratio (TTM)
-- - EPS (TTM)
-6.5760 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.
www.aclarion.comRecent News: ACONW
View MoreCompare To: ACONW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ACONW
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-115.33%
Return on Equity (ttm)
-714.18%
Revenue (ttm)
53.95k
Net Income Avi to Common (ttm)
-5.9M
Diluted EPS (ttm)
-6.5760
Balance Sheet and Cash Flow
Total Cash (mrq)
1.22M
Total Debt/Equity (mrq)
47.32%
Levered Free Cash Flow (ttm)
-3.94M